工程混合型兰蒂生物产生高度稳定和杀菌性Cerocin V
Longcheng Guo1, Konstantin Stoffels1, Jaap Broos1
1Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, the Netherlands.
Microbiological research
|February 13, 2024
概括
工程抗微生物 (AMP) 提供了对抗药物耐药细菌的新希望. 研究人员创造了新的杂交AMP,如素V,表现出增强的稳定性和强大的活性,没有毒性,为新的抗生素治疗铺平了道路.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 抗微生物 (AMP) 是对抗药物耐药性感染的常规抗生素有希望的替代品.
- 尼辛是一种经过充分研究的AMP,具有治疗潜力,但由于生理条件的不稳定性而受到限制.
- 通过合理设计调节AMP的物理化学决定因素,可以为新疗法产生具有所需生物特性的.
研究的目的:
- 通过结合nisin变体的域来设计新的混合AMP,以增强稳定性和抗菌活性.
- 为了识别和表征一种新的AMP变体,该变体具有改善的抗降解性和维持的功效.
- 在生理条件下评估工程AMP的安全性和稳定性.
主要方法:
- 通过从nisin A,cesin 和rombocin变体进行域混合来创建杂交AMP.
- 鉴定和描述一种新型变体,素A,以及其进一步突变为素V.
- 对抗美西林耐药黄金葡萄球菌 (MRSA) 的抗菌活性的评估.
- 评估素V对素降解的耐药性,对人类红细胞的毒性以及人类血中的稳定性.
主要成果:
- 一种25氨基酸混合型AMP,cerocin A,被确定具有对MRSA的强烈抗菌活性.
- 素A具有双重的作用模式,从细菌静止转变为杀菌.
- 赛洛辛V显著改善了对素降解的耐药性,同时保持了高的抗菌作用力.
- 赛洛辛V对人类红细胞没有毒性,在人体血中稳定.
结论:
- 基域工程是优化AMP生物和物理化学性能的有效策略.
- 像素V这样的工程AMP代表了新型抗生素开发的有希望的候选人.
- 开发的混合AMP为治疗抗生素耐药细菌引起的感染提供了潜在的解决方案.
相关概念视频
00:57Antibiotic Selection
53.5K
Overview
53.5K
01:23Antimicrobial Proteins
992
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
992
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:30Lytic Cycle of Bacteriophages
70.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.7K
01:18Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K